Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
PodcastExplore how Weaver’s digital transformation practice grew from the Permian Basin and how AI supports faster decisions and operational improvements.
Learn how purchase price allocations impact upstream energy deals, including PDPs, PUDs, recapture and equipment valuation. Watch now.
Learn why Texas is a leading life sciences hub, from workforce to funding. Discover what’s driving growth and what it means for companies.
Learn how severance tax planning, deductions and exemptions can reduce risk and improve cash flow for energy companies. Watch now.
Explore state and property tax compliance, appeals and valuation strategies helping oil and gas companies manage risk and reduce unexpected costs.
Discover why energy companies remain stuck in AI pilot phase, and learn the organizational agility framework that drives successful deployment.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Weaver’s Mike Collier examines recent trends in private equity investments in energy transition projects and the sector’s driving deal activity.
Explore Q2 2025 trends in Texas life sciences, from capital selectivity and pipeline constraints to market recovery and beyond.
